Gilead Sciences (GILD) Acquisitions (2011 - 2026)
Gilead Sciences' Acquisitions came in at $11.21 billion for Q2 2026, compared with $21 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Acquisitions (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported Acquisitions of $12.09 billion; for FY2025, it was $1.07 billion, down 77.9% from FY2024.
- Acquisitions carries a five-year compound annual growth rate of -47.1% (FY2020 to FY2025).
- Going back by year, Acquisitions was $4.84 billion in FY2024 (+320.1%), $1.15 billion in FY2023 (-35.9%), $1.8 billion in FY2022 (+13.4%) and $1.58 billion in FY2021 (-93.9%).
- The Q2 2026 figure represents the highest quarterly Acquisitions since Q4 2020.
- Year-over-year, Acquisitions increased in two of the last seven quarters, with growth averaging 135.7%.
- The fastest year-over-year change in Acquisitions over five years came in Q4 2025 (growth of 712.0%), and the weakest in Q4 2021 (a decline of 99.8%).
- Business Quant data shows GILD's Acquisitions at $109 million (Q1 2026), $609 million (Q4 2025) and $167 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -23.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.21 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | 91.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.21 Bn |
| Mar 31, 2026 | 109.00 Mn |
| Dec 31, 2025 | 609.00 Mn |
| Sep 30, 2025 | 167.00 Mn |
| Jun 30, 2025 | 21.00 Mn |
| Mar 31, 2025 | 273.00 Mn |
| Dec 31, 2024 | 75.00 Mn |
| Sep 30, 2024 | 570.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Mar 31, 2024 | 4.04 Bn |
| Dec 31, 2023 | 279.00 Mn |
| Sep 30, 2023 | 79.00 Mn |
| Jun 30, 2023 | 243.00 Mn |
| Mar 31, 2023 | 551.00 Mn |
| Dec 31, 2022 | 218.00 Mn |
| Sep 30, 2022 | 448.00 Mn |
| Jun 30, 2022 | 324.00 Mn |
| Mar 31, 2022 | 807.00 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Sep 30, 2021 | 83.00 Mn |
API Access
Gilead Sciences Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();